DTX-168-201 Study Site — Indianapolis, Indiana

DTX-168-201 Study Site is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

DTX-168-201 Study Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Fuchs Endothelial Corneal Dystrophy, Fuchs.

Sponsors: Design Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DTX-168-201 Study Site?

DTX-168-201 Study Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DTX-168-201 Study Site conducted?

DTX-168-201 Study Site has 1 clinical trials on record, with 1 currently active. Their work covers Fuchs Endothelial Corneal Dystrophy, Fuchs.

Is DTX-168-201 Study Site accredited by Crixeo Clinical Trials?

DTX-168-201 Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DTX-168-201 Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.